Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SIM0237 |
Synonyms | |
Therapy Description |
Limited information is currently available on SIM0237, a putative CD274 (PD-L1) and IL-15 bispecific antibody (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SIM0237 | SIM-0237|SIM 0237 | PD-L1/PD-1 antibody 117 | Limited information is currently available on SIM0237, a putative CD274 (PD-L1) and IL-15 bispecific antibody (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05781360 | Phase I | SIM0237 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors | Recruiting | USA | 1 |